Navigation Links
Study: Redefining the criteria for ALK positive lung cancer
Date:9/10/2013

A University of Colorado Cancer Center study published today in the journal Cancer shows that the current criteria used to match lung cancers with the drug crizotinib may miss some patients who could benefit from the drug. The findings suggest that doctors should look closer at borderline or atypical ALK-negative cases, and could widen the population of lung cancer patients offered treatment with crizotinib or other ALK-inhibitor drugs.

ALK stands for anaplastic lymphoma kinase, a gene that is turned off in most adult tissues in the body, but which can be re-activated to cause cancer when it is fused with another nearby gene. The original and still most widely-used test for ALK-positive lung cancer was co-developed by Leila Garcia, PhD, director of the Cytogenetics Core Resource at the University of Colorado Cancer Center. The test uses the technique known as fluorescence in situ hybridization (FISH) to test for the fusion of the ALK gene with another gene that turns ALK back on, allowing it to drive some lung cancers. When a cancer is ALK positive it can be very effectively treated with crizotinib, a targeted anti-ALK drug.

"The test is fairly definitive either a cell is ALK positive or not using the criteria we initially implemented. However, what is less certain is the exact percentage of ALK-positive cells required to label an entire tumor as ALK-positive. Is there an exact threshold of ALK-positive cells that will make a patient respond to crizotinib or other ALK inhibitors?" Garcia says.

"Since the beginning we have looked at the cells in a tumor and if 15 percent or more of these cells show the changes classically associated with an ALK rearrangement, we classify that tumor as ALK-positive and offer treatment with crizotinib," says Ross Camidge, MD, PhD, investigator at the CU Cancer Center and director of the thoracic oncology clinical program at University of Colorado Hospital.

Previous studies indicated that this 15-percent p
'/>"/>

Contact: Erika Matich
erika.matich@comcast.net
303-724-1528
University of Colorado Denver
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. ACR, SBI on cancer study: More breast cancer screening needed in younger women
2. Study: Disease caused by repeat brain trauma in athletes may affect memory, mood, behavior
3. Study: Many evangelicals are ambivalent about homosexuality and civil unions for gays
4. Study: Heart pump with behind-the-ear power connector
5. Study: Centers throughout the brain work together to make reading possible
6. Study: Taxing sugary beverages not a clear cut strategy to reduce obesity
7. Study: Taxing Sugary Beverages Not a Clear Cut Strategy to Reduce Obesity
8. Study: EBV Mononucleosis Risk Increased by Smoking and Family Size; polyDNA Recommends Gene-Eden-VIR Against the Latent EBV
9. New Study: Alcohol Drinkers May Face Long Term Health Issues
10. Beaumont Study: Nerve Stimulation Helps with Overactive Bladder
11. Study: Ipilimumab Shows Durable Responses But Low Overall Response Rate In Patients With Unresectable Or Metastatic Mucosal Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... ... July 07, 2015 , ... Silverado today issues its first ... early as Summer 2015 on a four-acre site in Bellingham, Washington. Cordata Design Review ... of city officials and other members of the local community. , The new complex ...
(Date:7/7/2015)... ... July 07, 2015 , ... The ... a mark on the cosmetic surgery industry with its commitment, teamwork, and dedication ... VisitandCare.com partnered medical provider is committed to patient safety, world-class results, and compassionate ...
(Date:7/7/2015)... ... , ... Owners of Green Ladies Cleaning are very pleased to announce that ... honor can only be gained by votes from Madison Magazine readership. , The company ... methods they use daily. Having a home cleaned with all-natural products means that residents ...
(Date:7/7/2015)... , ... July 07, 2015 , ... ... screenings at the Aspen Ideas Festival (AIF), identifying 18 possible melanomas and 46 ... must be confirmed with additional testing. , The Aspen Ideas Festival, which was ...
(Date:7/7/2015)... ... ... Ticket Down is a reputable source of authentic tickets for the 2015 CONCACAF Gold Cup ... at the Toyota Stadium. , The 2015 CONCACAF Gold Cup is now upon us ... held on American soil, will kick off in Frisco, CA from the Toyota Stadium and ...
Breaking Medicine News(10 mins):Health News:New Silverado Memory Care Community Receives Unanimous Approval from Design Review Board 2Health News:Top Plastic Surgery Provider in Brazil Joins VisitandCare.com 2Health News:Top Plastic Surgery Provider in Brazil Joins VisitandCare.com 3Health News:Environmentally-Friendly House Cleaning Company Wins Best of Madison Magazine Award 2Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 2Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 3Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 4Health News:Panama vs Haiti & USA vs Honduras CONCACAF Group A Tickets at Toyota Stadium: Ticket Down Slashes Ticket Prices for Haiti vs Panama & USA vs Honduras in Frisco/Dallas 2Health News:Panama vs Haiti & USA vs Honduras CONCACAF Group A Tickets at Toyota Stadium: Ticket Down Slashes Ticket Prices for Haiti vs Panama & USA vs Honduras in Frisco/Dallas 3
... Those with less than 12 years, schooling make more trips ... News) -- There,s good news for high-school graduates: Researchers have ... Those with fewer than 12 years of education had worse ... emergency rooms, Canadian researchers reported Dec. 17 in the journal ...
... The holidays are meant ... is seriously or terminally ill, those things might seem to be in short supply. Joni Aldrich ... , ... Take a look at any storefront window or television special: the holidays are meant to be ...
... ... American Society of Aesthetic Plastic Surgery indicates new trends and a significant jump in the ... surgeon in St. Louis , says one group of women he sees more and more ... procedure designed specifically for them. , ...
... ... ICD-10 implementation training to providers, outpatient clinics and health plans in preparation for the ... ... Professional Coders and Ingenix today announced a collaborative training effort that ...
... , WASHINGTON, Dec. 17 A ... killed in the Senate this week by self-styled moderates who claimed ... of costs by the Congressional Budget Office (CBO) has not yet ... year, found that there would be no public cost, yet consumers ...
... , NASDAQ: CRME TSX: ... (NASDAQ: CRME / TSX: COM) today announced that ... evaluating vernakalant (iv) versus amiodarone for the acute conversion of ... achieved statistical significance in demonstrating the superiority of vernakalant (iv) ...
Cached Medicine News:Health News:Facing the Holidays with a Heavy Heart: Four Ways to Show You Care During a Darker Christmas Season 2Health News:Facing the Holidays with a Heavy Heart: Four Ways to Show You Care During a Darker Christmas Season 3Health News:St. Louis Plastic Surgeon Renews Curves and Self-Esteem in New Mothers as Fresh Trends in Cosmetic Enhancement Emerge 2Health News:St. Louis Plastic Surgeon Renews Curves and Self-Esteem in New Mothers as Fresh Trends in Cosmetic Enhancement Emerge 3Health News:St. Louis Plastic Surgeon Renews Curves and Self-Esteem in New Mothers as Fresh Trends in Cosmetic Enhancement Emerge 4Health News:The American Academy of Professional Coders and Ingenix to Offer Comprehensive ICD-10 Implementation Training 2Health News:The American Academy of Professional Coders and Ingenix to Offer Comprehensive ICD-10 Implementation Training 3Health News:The American Academy of Professional Coders and Ingenix to Offer Comprehensive ICD-10 Implementation Training 4Health News:2008 CBO Report Favorably Scored the Medicare Buy-In 2Health News:Cardiome Announces Investigational Candidate, Vernakalant, Meets Primary Endpoint in European Comparator Study 2Health News:Cardiome Announces Investigational Candidate, Vernakalant, Meets Primary Endpoint in European Comparator Study 3Health News:Cardiome Announces Investigational Candidate, Vernakalant, Meets Primary Endpoint in European Comparator Study 4
(Date:7/7/2015)... , July 7, 2015   Decision Resources ... differences in dialysis patient management in the U.S. ... submitted by U.S. and EU5 nephrologists from approximately ... binders are the most commonly used renal medications ... iron differs considerably between the two regions.      ...
(Date:7/7/2015)... , July 7, 2015 The ... USD 1,197.7 million by 2020, growing at an estimated CAGR ... study by Grand View Research, Inc. Introduction of innovative technologies ... with growing awareness levels pertaining to the advantages of breast ... next six years. In addition, presence of untapped growth opportunities ...
(Date:7/7/2015)... , July 7, 2015 EnteroMedics Inc. ... devices that use neuroblocking technology to treat obesity, metabolic ... its previously announced public offering of 32,000,000 units. Each unit ... Series A warrant to purchase one share of common ... Investors whose purchase of units in the offering would ...
Breaking Medicine Technology:Similarities And Differences Exist When Comparing U.S. Versus EU5 Dialysis Patient Management 2Similarities And Differences Exist When Comparing U.S. Versus EU5 Dialysis Patient Management 3Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 2Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 3Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 4EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants 3
... SAN RAFAEL, Calif. , Aug. 4 To ... companies have selected New Momentum, the leading SaaS-based anti-counterfeiting solution.  Both ... and shut down violators, their New Momentum solution will play a ... , , ...
... Aug. 4 Cytel Inc., premier provider of adaptive clinical trial ... software package for adaptive dose-finding studies based on frequentist or Bayesian methods. , ... The FDA,s recently issued adaptive trial guidelines ... level.  , , , ...
Cached Medicine Technology:Two More Global Pharmaceutical Companies Choose New Momentum to Stop Counterfeits 2Cytel Announces CompassĀ® - The Only Professional Adaptive Trial Software Package for Bayesian or Frequentist Dose-Finding Studies 2Cytel Announces CompassĀ® - The Only Professional Adaptive Trial Software Package for Bayesian or Frequentist Dose-Finding Studies 3
A single tube that performs two rapid tests for E. coli from culture. ColiScreen™ combines both the indole test with the glucuronidase test to increase the specificity....
Legionella provides rapid, accurate results that aid in the presumptive diagnosis of Legionella infection (Legionnaires' Disease)....
... The Trinity Biotech Captia™ ... Assay (ELISA) is intended for ... antibodies (IgG and IgM) to ... in serum from patients with ...
The GoodKnight® 425 Bi-Level® device is suitable for travel and includes features such as automatic altitude compensation, optional cigarette lighter adapter and portable battery pack...
Medicine Products: